Related Experiment Video
Updated: Feb 7, 2026

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes
Published on: August 9, 2022
Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle
Petr G Vikhorev1, Natalia N Vikhoreva2
1National Heart and Lung Institute, Imperial College London, London W12 0NN, UK. p.vikhorev@imperial.ac.uk.
Insights
Genetic mutations in sarcomeric and non-sarcomeric proteins cause cardiomyopathies by affecting heart muscle contractility. Further research is needed to fully understand how these genetic defects lead to disease progression.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiomyopathies, including hypertrophic and dilated forms, are often genetic.
- Sarcomeric proteins are crucial for cardiomyocyte contractility and structure.
- Non-sarcomeric protein mutations can alter cell signaling and cardiac function.
Purpose of the Study:
- To review the role of cardiac myofilament contractility in cardiomyopathy.
- To explore the link between genetic mutations and contractile dysfunction in heart failure.
Main Methods:
- Literature review of studies on genetic cardiomyopathies.
- Analysis of research on sarcomeric and non-sarcomeric protein function.
- Examination of data on cardiac myofilament mechanics in patients.
Main Results:
- Approximately 50% of cardiomyopathy cases are linked to sarcomeric protein mutations.
- Contractile dysfunction is a central feature in the initiation and progression of cardiomyopathies.
- Abnormalities in myofibril contractile mechanics are evident in affected individuals.
Conclusions:
- Genetic mutations significantly impact cardiac contractility, contributing to cardiomyopathy development.
- Understanding the precise mechanisms by which mutations cause disease remains an active area of research.
Abstract:
About half of hypertrophic and dilated cardiomyopathies cases have been recognized as genetic diseases with mutations in sarcomeric proteins. The sarcomeric proteins are involved in cardiomyocyte contractility and its regulation, and play a structural role. Mutations in non-sarcomeric proteins may induce changes in cell signaling pathways that modify contractile response of heart muscle. These facts strongly suggest that contractile dysfunction plays a central role in initiation and progression of cardiomyopathies. In fact, abnormalities in contractile mechanics of myofibrils have been discovered. However, it has not been revealed how these mutations increase risk for cardiomyopathy and cause the disease. Much research has been done and still much is being done to understand how the mechanism works. Here, we review the facts of cardiac myofilament contractility in patients with cardiomyopathy and heart failure.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
The Contractile Ring
A small GTPase, RhoA, controls the function and assembly of the contractile ring. RhoA belongs to the Ras superfamily of proteins. The activation of formins by RhoA promotes...
Anatomy of the Heart
Cardiomyopathy V: Interprofessional Care

